InteloMed Named Tech 50 Innovator of the Year Finalist in Life Sciences for 2016

Pittsburgh Technology Council Recognizes Companies with  Innovative and Transformative Technologies

 

PITTSBURGH, PA (August 23, 2016)– InteloMed, Inc., an emerging leader in non-invasive cardiovascular monitoring and developer of the CVInsight® Patient Monitoring & Informatics System, announced today that the Pittsburgh Technology Council has named it as a Tech 50 Finalist as Innovator of the Year: Life Sciences.
The Pittsburgh Technology Council’s Annual Tech 50 Awards recognize southwestern Pennsylvania’s transformative technology centers of excellence with tech companies at all stages of growth.
“Our mission is to empower clinicians with meaningful and actionable data on the dynamic cardiovascular system,” commented Jill Schiaparelli, President and CEO of InteloMed. “We are honored that the Pittsburgh Technology Council has named InteloMed as a Tech 50 Finalist in Life Sciences, recognizing the impact the CVInsight® System can provide for the large and vulnerable dialysis patient population. In particular, clinicians value the real-time insight it adds to their assessment of individual patient cardiovascular stress.”
For more information on Tech 50 Finalists, visit http://www.pghtech.org/events/tech-50/tech-50-2016-finalists.aspx. For more information on the Pittsburgh Technology Council, visit www.pghtech.org.
About InteloMed
InteloMed is redefining the standard of care in patient monitoring and informatics through its CVInsight® Patient Monitoring & Informatics Platform. We believe that non-invasive, easy-to-use, real-time patient monitoring and informatics solutions offer an advanced alternative to invasive approaches, such as implantable devices and catheters, and to less invasive “spot check” approaches such as blood pressure cuffs. The CVInsight® System provides relevant and actionable health information for at-risk patients throughout the care pathway. For more information, visit us at www.InteloMed.com.

Safe Harbor Statement
Certain statements in this release are “forward-looking” and as such are subject to numerous risks and uncertainties. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause actual results to materially differ from forward-looking statements include, but are not limited to, the need to obtain additional capital in order to grow our business, our ability to engage qualified employees, the acceptance of new products by doctors and hospitals, changes in the regulatory environment and healthcare legislation, the need to keep pace with technological changes, our dependence on third party manufacturers to produce components of our technology platform on time and to our specifications, and the successful implementation of our commercial strategies.

 

CONTACT

InteloMed, Inc.
Mike Dignazio, CFO
412.536.7654
MDignazio@InteloMed.com

PR / Media Contact:
Matthew Bird
President
1-800-PublicRelations, Inc.
646.401.4499
matt.bird@1800pr.com

Recent Posts